Drug Pipeline

Rezpegaldesleukin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07142252 Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus Type 1 Diabetes Mellitus Recruiting
NCT06340360 A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to… Alopecia Areata Active, Not Recruiting
NCT06136741 A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult… Moderate to Severe Atopic Dermatitis Active, Not Recruiting
Sponsors Running Rezpegaldesleukin Trials
Nektar Therapeutics (2) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
Disease Areas
Atopic Dermatitis (1) Type 1 Diabetes (1) Diabetes (1)
Get alerts when Rezpegaldesleukin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free